JAVIER A ADACHI to Adult
This is a "connection" page, showing publications JAVIER A ADACHI has written about Adult.
Connection Strength
0.168
-
Safety, Efficacy, and Clinical Impact of Penicillin Skin Testing in Immunocompromised Cancer Patients. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2185-2191.e1.
Score: 0.025
-
Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis. 2010 Feb 01; 50(3):374-80.
Score: 0.013
-
Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis. 2003 Nov 01; 37(9):1165-71.
Score: 0.009
-
Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico. J Infect Dis. 2002 Jun 01; 185(11):1681-3.
Score: 0.008
-
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis. 2001 Jun 15; 32(12):1706-9.
Score: 0.007
-
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients. Front Immunol. 2021; 12:675679.
Score: 0.007
-
Atypical cases of necrotizing sweet syndrome in patients with myelodysplastic syndrome and acute myeloid leukaemia. Br J Haematol. 2020 10; 191(1):e10-e13.
Score: 0.007
-
Neutropenic Enterocolitis: Clinical Features and Outcomes. Dis Colon Rectum. 2020 03; 63(3):381-388.
Score: 0.007
-
Reactive arthritis associated with typhoid vaccination in travelers: report of two cases with negative HLA-B27. J Travel Med. 2000 Jan; 7(1):35-6.
Score: 0.007
-
A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation. Clin Infect Dis. 2019 01 07; 68(2):196-203.
Score: 0.006
-
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa. Clin Infect Dis. 2017 07 01; 65(1):158-161.
Score: 0.006
-
The use of fidaxomicin for treatment of relapsed Clostridium difficile infections in patients with cancer. Pharmacotherapy. 2014 Nov; 34(11):1220-5.
Score: 0.005
-
Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions. Clin Infect Dis. 2014 Nov 01; 59(9):1277-80.
Score: 0.005
-
Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clin Microbiol Infect. 2014 Oct; 20(10):O672-9.
Score: 0.004
-
A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes. Cancer. 2012 Sep 15; 118(18):4627-33.
Score: 0.004
-
Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-?-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother. 2012 May; 56(5):2364-70.
Score: 0.004
-
The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood. 2012 Mar 22; 119(12):2738-45; quiz 2969.
Score: 0.004
-
Norovirus gastroenteritis successfully treated with nitazoxanide. J Infect. 2011 Nov; 63(5):394-7.
Score: 0.004
-
Serratia marcescens bacteremia because of contaminated prefilled heparin and saline syringes: a multi-state report. Am J Infect Control. 2011 Aug; 39(6):521-4.
Score: 0.004
-
Viral pneumonias in immunocompromised adult hosts. J Intensive Care Med. 2010 Nov-Dec; 25(6):307-26.
Score: 0.004
-
Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010 Aug; 36(2):182-6.
Score: 0.003
-
Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore). 2009 Jul; 88(4):211-220.
Score: 0.003
-
Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control. 2009 Nov; 37(9):741-5.
Score: 0.003
-
Disseminated salmonellosis in a patient treated with temozolomide. J Infect. 2008 Nov; 57(5):414-5.
Score: 0.003
-
The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer. J Antimicrob Chemother. 2008 Feb; 61(2):421-4.
Score: 0.003
-
Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol. 2007 Apr; 5(4):451-6.
Score: 0.003
-
Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005 Oct; 41(15):2268-79.
Score: 0.002
-
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis. 2001 Dec 01; 33(11):1807-15.
Score: 0.002
-
Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara, Mexico. Scand J Infect Dis. 2001; 33(11):812-4.
Score: 0.002
-
Markers of enteric inflammation in enteroaggregative Escherichia coli diarrhea in travelers. Am J Trop Med Hyg. 2000 Jun; 62(6):711-3.
Score: 0.002
-
Intestinal secretory immunoglobulin A response to enteroaggregative Escherichia coli in travelers with diarrhea. Clin Diagn Lab Immunol. 2000 May; 7(3):501-3.
Score: 0.002
-
Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin. Clin Infect Dis. 1999 Aug; 29(2):335-8.
Score: 0.002